The UK pharmaceutical industry has cut more than 10% of its workforce over the past three years, according to the Daily Telegraph.
The paper reports on figures releases by the Association of the British Pharmaceutical Industry (ABPI). The ABPI say that the shrinking of the industry is directly related to changes in the way the state pays for prescription drugs, known as the Pharmaceutical Price Regulation Scheme (PPRS).
The closure of a manufacturing plant in Kent by US pharmaceutical giant Pfizer has been followed by the announcement of further cuts in the workforce at UK companies AstraZeneca and GlaxoSmithKline.
The UK government is said to be looking for a reduction in its £11 billion annual expenditure on prescription drugs of up to 10%.
The ABPI surveyed 15 large, medium and small companies in the sector, representing about two-thirds of the industry.